Opportunity Information: Apply for RFA CA 23 042

The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed), listed under Funding Opportunity Number RFA-CA-23-042, is a National Cancer Institute (NCI) program within the National Institutes of Health (NIH) designed to help exceptional PhD (or equivalent) graduate students move efficiently from the late predoctoral stage into strong postdoctoral cancer research positions and, ultimately, toward independent research careers. The core idea is to identify trainees who have already been recognized by their institutions as unusually promising and deeply committed to cancer research, then give them structured support that bridges the often difficult transition from dissertation work to a productive, career-building postdoc. As the title indicates, this opportunity does not allow clinical trials, so proposed work must stay within the non-clinical-trial scope as defined by NIH.

The award is structured as a transition mechanism, meaning it is meant to cover two linked phases of training and career development. The F99 portion supports the final stage of graduate training, helping the fellow complete key predoctoral milestones while positioning them competitively for postdoctoral recruitment. The K00 portion then provides mentored support during the postdoctoral period, with an emphasis on building the skills, record of accomplishment, and professional trajectory needed to become an independent cancer researcher. Across both phases, NCI expects the recipient to pursue not only high-quality cancer-relevant research, but also intentional career development activities aligned with their long-term goal of research independence. In practical terms, that typically means a thoughtful plan for mentorship, training experiences, and professional development that go beyond day-to-day bench or computational work and clearly build toward independence.

In terms of who can apply as an eligible applicant organization, the opportunity is broadly open across many U.S.-based entities and organizational types that commonly participate in NIH funding. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations other than federally recognized tribal governments; public housing authorities/Indian housing authorities; nonprofits (both 501(c)(3) and non-501(c)(3), excluding institutions of higher education in those nonprofit categories); for-profit organizations other than small businesses; small businesses; and other eligible entities. NCI also explicitly highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, Indian/Native American tribal governments that are not federally recognized, and U.S. territories or possessions. This broad eligibility language reflects NIH’s interest in supporting talent across many institutional settings and communities.

At the same time, there are important limitations related to non-U.S. involvement. Non-domestic (non-U.S.) entities (foreign organizations) and non-domestic (non-U.S.) entities that are foreign institutions are not eligible to apply as applicant organizations. Non-domestic components of U.S. organizations are also not eligible to apply. However, foreign components are allowed as defined in the NIH Grants Policy Statement, which generally means a U.S. applicant organization may include certain well-justified foreign elements of the project when permitted under NIH rules, even though the primary applicant organization must be domestic.

Administratively, this is a discretionary grant funding opportunity in the Education and Health activity area, with CFDA number 93.398, offered by NIH/NCI. The posting lists an original closing date of 2024-11-19. While the excerpt provided does not specify an award ceiling or the expected number of awards, the intent and structure are clearly focused on investing in a pipeline of highly promising cancer researchers at a key career transition point, pairing research training with deliberate career development so that recipients are better positioned to secure strong postdoctoral appointments and progress toward independent investigator status.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.398.
  • This funding opportunity was created on 2023-08-21.
  • Applicants must submit their applications by 2024-11-19. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA CA 23 042

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

FAQs: NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed) - RFA-CA-23-042

What is the NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)?

This opportunity is a National Cancer Institute (NCI) program within the National Institutes of Health (NIH) designed to help exceptional PhD (or equivalent) graduate students transition efficiently from the late predoctoral stage into strong postdoctoral cancer research positions and, ultimately, toward independent research careers. It supports both research training and intentional career development during this key transition.

What is the funding opportunity number for this award?

The Funding Opportunity Number (FOA) is RFA-CA-23-042.

What does "Clinical Trial Not Allowed" mean for this FOA?

It means proposed work must remain outside the clinical trial scope as defined by NIH. Applicants should plan research that is cancer-relevant but does not meet NIH's definition of a clinical trial.

What is the main purpose of this award?

The main purpose is to identify trainees recognized by their institutions as unusually promising and committed to cancer research, then provide structured support that bridges the transition from dissertation work to a productive postdoc. The goal is to strengthen the recipient's trajectory toward research independence.

How is the award structured?

The award is a transition mechanism with two linked phases:

  • F99 phase: Supports the final stage of graduate training, helping the fellow complete key predoctoral milestones and become more competitive for postdoctoral recruitment.
  • K00 phase: Provides mentored support during the postdoctoral period, emphasizing skill-building, productivity, and career development toward independent cancer research.

What is expected of recipients across both phases?

NCI expects recipients to pursue high-quality, cancer-relevant research and to carry out intentional career development activities aligned with long-term independence. This commonly includes a thoughtful mentorship plan, training experiences, and professional development activities that go beyond routine day-to-day research work.

Who is this program designed to help?

It is designed for exceptional PhD (or equivalent) graduate students in the late predoctoral stage who are moving toward postdoctoral cancer research positions and who are aiming for independent research careers.

What types of organizations are eligible to apply?

A wide range of U.S.-based organizations are eligible to apply as the applicant organization, including:

  • State, county, city, or township governments
  • Special district governments
  • Independent school districts
  • Public and state-controlled institutions of higher education
  • Private institutions of higher education
  • Federally recognized Native American tribal governments
  • Native American tribal organizations other than federally recognized tribal governments
  • Public housing authorities/Indian housing authorities
  • Nonprofits (501(c)(3) and non-501(c)(3), excluding institutions of higher education in those nonprofit categories)
  • For-profit organizations other than small businesses
  • Small businesses
  • Other eligible entities

Are minority-serving institutions and community-based organizations included in eligibility?

Yes. NCI explicitly highlights additional eligible applicant categories including Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, Hispanic-serving Institutions, HBCUs, TCCUs, and faith-based or community-based organizations, among others.

Are U.S. territories or possessions eligible?

Yes. U.S. territories or possessions are listed among the explicitly highlighted eligible applicant categories.

Can non-U.S. (foreign) organizations apply as the applicant organization?

No. Non-domestic (non-U.S.) entities (foreign organizations) and non-domestic entities that are foreign institutions are not eligible to apply as applicant organizations for this opportunity.

Can a non-domestic component of a U.S. organization apply?

No. Non-domestic components of U.S. organizations are not eligible to apply.

Are foreign components allowed at all under this opportunity?

Yes. Foreign components are allowed as defined in the NIH Grants Policy Statement. In general terms, this means a U.S. applicant organization may include certain well-justified foreign elements of the project when permitted under NIH rules, even though the primary applicant organization must be domestic.

Which federal agency is offering this opportunity?

The opportunity is offered by the National Institutes of Health (NIH), specifically the National Cancer Institute (NCI).

What type of grant is this?

It is a discretionary grant funding opportunity.

What activity area is associated with this opportunity?

The activity area is listed as Education and Health.

What is the CFDA number associated with this opportunity?

The CFDA number is 93.398.

What is the closing date listed for this opportunity?

The posting lists an original closing date of 2024-11-19.

Does the provided information list an award ceiling or number of awards?

No. The excerpt provided does not specify an award ceiling or the expected number of awards.

What is the long-term career outcome NCI is trying to support with this award?

The long-term outcome is to help recipients secure strong postdoctoral appointments and progress toward independent investigator status in cancer research by pairing mentored research training with deliberate career development.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: HEAL Initiative: Justice Community Overdose Innovation Network (JCOIN) - Phase II Methodology and Advanced Analytics Resource Center (UM1 Clinical Trial Not Allowed)

Previous opportunity: Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD)?(U01 Clinical Trial Optional)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA CA 23 042

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA CA 23 042) also looked into and applied for these:

Funding Opportunity
Engaging Survivors of Sexual Violence and Trafficking in HIV and Substance Use Disorder Services (R34 Clinical Trial Optional) Apply for RFA DA 25 018

Funding Number: RFA DA 25 018
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional) Apply for PAR 23 279

Funding Number: PAR 23 279
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed) Apply for PAR 23 280

Funding Number: PAR 23 280
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $275,000
Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01) Apply for PAR 24 027

Funding Number: PAR 24 027
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Single Source: Pediatric Early Phase Clinical Trials Network (PEP-CTN; UM1 Clinical Trial Required) Apply for RFA CA 24 007

Funding Number: RFA CA 24 007
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Biotypes of CNS Complications in People Living with HIV (P01 Clinical Trial Not Allowed) Apply for RFA MH 24 235

Funding Number: RFA MH 24 235
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Firearm Injury Prevention in Community Healthcare Settings (R01 Clinical Trial Optional) Apply for RFA NR 24 001

Funding Number: RFA NR 24 001
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional) Apply for PAR 23 292

Funding Number: PAR 23 292
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Cohort Studies of HIV/AIDS and Substance Use (U01 Clinical Trial Not Allowed) Apply for RFA DA 25 003

Funding Number: RFA DA 25 003
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
HEAL Initiative: Developing an Evidence Base for Co-Occurring OUD-AUD Interventions (R34 Clinical Trial Optional) Apply for RFA AA 23 006

Funding Number: RFA AA 23 006
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
HEAL Initiative: Developing an Evidence Base for Co-Occurring OUD-AUD Interventions (R01 Clinical Trial Optional) Apply for RFA AA 23 005

Funding Number: RFA AA 23 005
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
NIDA REI: Academic Research Enhancement Award (AREA) Training a Diverse Data Science Workforce for Addiction Research (R15 Clinical Trial Not Allowed) Apply for RFA DA 24 026

Funding Number: RFA DA 24 026
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
NIDA REI: Training a Diverse Data Science Workforce for Addiction Research (R25 Clinical Trial Not Allowed) Apply for RFA DA 24 025

Funding Number: RFA DA 24 025
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $125,000
Single Source: Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Coordination, Analysis, and Scientific Outreach (UM1 Clinical Trial Not Allowed) Apply for RFA DA 25 015

Funding Number: RFA DA 25 015
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed) Apply for PAR 23 277

Funding Number: PAR 23 277
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional Validation (R01 Clinical Trial Not Allowed) Apply for RFA DA 25 016

Funding Number: RFA DA 25 016
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $350,000
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional Validation (R21 Clinical Trial Not Allowed) Apply for RFA DA 25 017

Funding Number: RFA DA 25 017
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $275,000
Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed) Apply for PAR 23 278

Funding Number: PAR 23 278
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R01 Clinical Trial Optional) Apply for RFA DA 24 067

Funding Number: RFA DA 24 067
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R61/R33 Clinical Trial Optional) Apply for RFA DA 24 066

Funding Number: RFA DA 24 066
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 23 042", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: